Langerhans cell histiocytosis (LCH) is a rare inflammatory disorder of myeloid dendritic cells with mutations involving KRAS, BRAF and/or NRAS, and MAP2K1 genes. We describe the case of a 58-year-old female previous smoker with multifocal LCH involving the lungs, pituitary gland and mandibular bone. Initial treatment with 6 cycles of cladribine showed improvement in her extrapulmonary lesions, however, her lung disease progressed and after qualification and assessment tests she underwent uncomplicated double lung transplant surgery and was discharged home. We highlight that in select patients with well managed and controlled extrapulmonary LCH, such an invasive procedure as lung transplant is possible.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transproceed.2022.02.037DOI Listing

Publication Analysis

Top Keywords

lung transplant
12
langerhans cell
8
cell histiocytosis
8
lung
4
transplant patient
4
patient multifocal
4
multifocal langerhans
4
histiocytosis chemotherapy
4
chemotherapy cladribine
4
cladribine case
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!